通过基于联体和结构的虚拟查来识别新的人类P2X7对手
Marika Zuanon1, Andrea Brancale2, Mark T Young1
1School of Biosciences, Cardiff University, Sir Martin Evans Building, Cardiff CF10 3AT, United Kingdom.
Journal of chemical information and modeling
|June 26, 2025
概括
研究人员使用虚拟查确定了新的P2X7受体对抗剂. 化合物2g显示出有前途的功效,为开发治疗炎症疾病和慢性疼痛的新途径提供了希望.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- P2X7受体与炎症和神经退行性疾病,慢性疼痛和癌症有关.
- 现有的P2X7抗剂由于药理动力学,选择性和疗效差,缺乏临床批准.
研究的目的:
- 使用虚拟查工作流程识别新的P2X7全抗体.
- 为了解决当前P2X7对抗剂候选者的局限性.
主要方法:
- 集成的基于连接体和基于结构的虚拟选~1000万个化合物.
- 使用了3D药模型,并与人类P2X7同类模型对接.
- 使用YO-PRO 1染料吸收和膜潜能红色试验测定化合物活性.
主要成果:
- 十一种化合物表现出类似药物的特性和与P2X7.7的关键相互作用.
- 六种化合物抑制了P2X7激活,其中两个 (2和9) 在第二次测试中显示活性.
- 化合物2g表现出强大的P2X7抑制 (IC50 = 1.31μM),并阐明了其结合方式.
结论:
- 已识别的化合物,特别是2g,代表了开发优化P2X7抗剂的有希望的起点.
- 这种虚拟查方法成功识别了新型全性P2X7抗剂.
- 进一步优化可能会导致临床上可行的P2X7向治疗方法.
更多相关视频
06:26Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
5.0K
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
380
相关概念视频
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Ligand Binding Sites
13.5K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.5K
